Plx-4032 NEW
| Price | $50 | $72 | $100 |
| Package | 10mg | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Plx-4032 | CAS No.: 1029872-54-5 |
| Purity: 99.94% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Plx-4032 |
| Description | Plx-4032 (Vemurafenib) is a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma. |
| In vivo | PLX-4032 and its related analogs are highly potent inhibitors of B-Raf activity, with 3-fold selectivity for the V600E mutation over the wild-type kinase.?In preclinical models, PLX-4032 and its analogs inhibited the growth of BRAFV600E-positive melanoma cell lines both in vitro and in vivo[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 7.29 mg/mL (14.88 mM), Solution. Ethanol : 1.41 mg/mL (2.88 mM), Sonication is recommended. DMSO : 72.86 mg/mL (148.72 mM), Sonication is recommended. 10% DMSO+90% Saline : < 7.29 mg/mL (14.88 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | Plx-4032 | Plx4032 | Plx 4032 | B-Raf | 18504-65-1 |
| Inhibitors Related | Regorafenib monohydrate | Exarafenib | Doramapimod | Vemurafenib | Sulindac sulfide | Sorafenib | Regorafenib | Dabrafenib | Dabrafenib Mesylate | LY3009120 | GW 441756 | RMC-7977 |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Membrane Protein-targeted Compound Library | Kinase Inhibitor Library | Anti-Obesity Compound Library | Post-Translational Modification Compound Library | Inhibitor Library | FDA-Approved Kinase Inhibitor Library | Covalent Inhibitor Library | NMPA-Approved Drug Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1700.00 |
VIP2Y
|
Shenzhen Nexcon Pharmatechs Ltd.
|
2026-07-01 | |
|
VIP3Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-07-01 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 | |
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-02 | ||
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-04-30 | ||
| $1.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 | |
|
VIP3Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-07-01 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY